USE OF CORTICOSTEROIDS IN A NORWEGIAN COHORT OF PATIENTS WITH IGA NEPHROPATHY AND RAPID PROGRESSION TO END-STAGE RENAL DISEASE

被引:0
|
作者
Haaskjold, Yngvar Lunde [1 ,2 ]
Rivedal, Mariell [2 ]
Lura, Njal Gjaerde [3 ]
Bjorneklett, Rune [2 ,4 ]
Knoop, Thomas [1 ,2 ]
机构
[1] Haukeland Univ Hosp Hlth Bergen, Med, Bergen, Norway
[2] Univ Bergen, Med Clin, Bergen, Norway
[3] Haukeland Univ Hosp Hlth Bergen, Radiol, Bergen, Norway
[4] Haukeland Univ Hosp Hlth Bergen, Emergency Care Clin, Bergen, Norway
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MO268
引用
收藏
页码:I192 / I192
页数:1
相关论文
共 50 条
  • [31] Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
    Kun Ling Ma
    Tie Kai Gong
    Ze Bo Hu
    Yang Zhang
    Gui Hua Wang
    Liang Liu
    Pei Pei Chen
    Jian Lu
    Chen Chen Lu
    Bi Cheng Liu
    BMC Nephrology, 19
  • [32] LIPOPROTEIN A CONTRIBUTES TO THE PROGRESSION OF ATHEROSCLEROSIS IN PATIENTS WITH END-STAGE RENAL DISEASE
    Ma, Kun Ling
    Gong, Tie Kai
    Hu, Ze Bo
    Zhang, Yang
    Wang, Gui Hua
    Lu, Jian
    Chen, Pei Pei
    Liu, Liang
    Liu, Bi Cheng
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [33] Albuminuria predicts progression to end-stage renal disease in diabetic patients
    Babazono, T.
    Murata, H.
    Toyonaga, A.
    Yoshida, N.
    Takemura, S.
    Takagi, M.
    Yoshida, N.
    Toya, K.
    Nyumura, I.
    Hanai, K.
    Tanaka, N.
    Uchigata, Y.
    DIABETOLOGIA, 2014, 57 : S486 - S486
  • [34] Lipoprotein(a) accelerated the progression of atherosclerosis in patients with end-stage renal disease
    Ma, Kun Ling
    Gong, Tie Kai
    Hu, Ze Bo
    Zhang, Yang
    Wang, Gui Hua
    Liu, Liang
    Chen, Pei Pei
    Lu, Jian
    Lu, Chen Chen
    Liu, Bi Cheng
    BMC NEPHROLOGY, 2018, 19
  • [35] THE NEFIGARD TRIAL: THE EFFECT OF NEFECON® (BUDESONIDE) IN PATIENTS WITH PRIMARY IGA NEPHROPATHY AT RISK OF DEVELOPING END-STAGE RENAL DISEASE
    Barratt, Jonathan
    Stone, Andrew
    Kristensen, Jens
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 532 - 532
  • [36] Primary renal amyloidosis in a young male with rapid progression to end-stage renal disease (ESRD).
    Shafique, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A55 - A55
  • [37] Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy
    Mohanram, A
    Zhang, Z
    Shahinfar, S
    Keane, WF
    Brenner, BM
    Toto, RD
    KIDNEY INTERNATIONAL, 2004, 66 (03) : 1131 - 1138
  • [38] IGA NEPHROPATHY - COMMON NEPHRITIS LEADING TO END-STAGE RENAL-FAILURE
    LAI, KN
    WANG, AYM
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1994, 17 (09): : 457 - 460
  • [39] Live donor renal transplantation in patients with end-stage renal failure due to IgA nephropathy: clinicopathological assessment
    Kim, YS
    Jeong, HJ
    Kwon, KW
    Lee, HY
    Han, DS
    Park, K
    NEPHROLOGY, 2002, 7 : S74 - S77
  • [40] Use of disease embedding technique to predict the risk of progression to end-stage renal disease
    Zhou, Fang
    Gillespie, Avrum
    Gligorijevic, Djordje
    Gligorijevic, Jelena
    Obradovic, Zoran
    JOURNAL OF BIOMEDICAL INFORMATICS, 2020, 105